|
Volumn 256, Issue 7, 2009, Pages 1182-1183
|
Rhabdomyolysis caused by co-medication with simvastatin and clarithromycin
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALLOPURINOL;
BISOPROLOL;
CLARITHROMYCIN;
GLIBENCLAMIDE;
HYDROCHLOROTHIAZIDE;
SIMVASTATIN;
TELMISARTAN;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ANAMNESIS;
ANTIBIOTIC THERAPY;
CASE REPORT;
CREATINE KINASE BLOOD LEVEL;
DRUG WITHDRAWAL;
FEMALE;
HUMAN;
LABORATORY TEST;
LETTER;
PRIORITY JOURNAL;
RHABDOMYOLYSIS;
SIDE EFFECT;
WEAKNESS;
AGED;
ANTI-BACTERIAL AGENTS;
CLARITHROMYCIN;
CYTOCHROME P-450 CYP3A;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG INTERACTIONS;
ENERGY METABOLISM;
FEMALE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
IATROGENIC DISEASE;
MUSCLE WEAKNESS;
MUSCLE, SKELETAL;
RHABDOMYOLYSIS;
RISK FACTORS;
SIMVASTATIN;
|
EID: 67650499611
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-009-5078-6 Document Type: Letter |
Times cited : (26)
|
References (8)
|